• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Risks of long-term tylenol use corroborated in meta-analysis

bys25qthea
March 4, 2015
in Chronic Disease
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. This recent meta-analysis found a slightly increased cardiovascular, renal, and gastrointestinal adverse outcomes with prolonged, chronic acetaminophen (tylenol/paracematol) use.

2. While dose-response relationships were seemingly found in the included studies, dosage definitions varied, study populations were not generalizable, and prospective studies were limited.

Evidence Rating Level: 2 (Good)           

Study Rundown: Acetaminophen (tylenol/paracetamol) is one of the most widely used analgesic medications around the world, and while it is often considered an over-the-counter medication, there are many risks associated with its use. As recent studies have cast some doubt on the efficacy of long-term acetaminophen use for chronic pain, a reassessment of the benefits and risks of the prolonged acetaminophen use. This meta-analysis compiled data from eight cohort studies, but was unable to analyze outcomes due to the non-comparable nature of the studies (different dosage definitions). However, the included studies showed increased gastrointestinal, renal, and cardiovascular adverse events when acetaminophen was taken chronically and for long periods of time.

The need to assess the relative safety of drugs as ubiquitous as acetaminophen is extremely important, but this study fell short of contributing much evidence to the existing literature. The inclusion of only eight cohort studies out of 1888 made it impossible to pool data, and the pre-meditated exclusion of RCTs, reportedly due to short follow-up times and homogeneous populations, is worrisome. Further, the studies that were included were often unable to compare acetaminophen to alternative analgesics, did not take into account adverse events due to the diseases the analgesics were prescribed for. They also lacked generalizability as most of the studies followed nurses or male physicians. This study also reports that all research included had low to very low quality of data. In addition, systematic reviews of short-term RCTs showed similar dose-related toxicity to those reported by this study, again raising doubts as to why RCTs were not included in this meta-analysis. It is clear that there are risks of prolonged acetaminophen use, but this study should not raise or lower clinician’s concern in prescribing or suggesting use of this medication any more than at present.

Click to read the study in Annals of Rheumatic Diseases

RELATED REPORTS

Triptans may be the most effective treatments available for acute episodic migraine

Addition of IV acetaminophen with propofol or dexmedetomidine reduces risk of post-operative delirium in older patients undergoing cardiac surgery

Acetaminophen reduces recurrence of febrile seizures in children within same fever episode

Relevant Reading: OARSI recommendations for the management of hip and knee osteoarthritis. Part III: changes in evidence following systematic cumulative update of research published through January 2009

In-Depth [meta-analysis]: 8 out of 1888 studies were included in this meta-analysis, with inclusion/exclusion criteria influenced by recommendations made by the Meta-analysis Observational Studies in Epidemiology and the Preferred Reporting Items for Systematic Reviews and Meta-analyses. Inclusion criteria were for studies to be observational, non-RCT studies of patients >18 years of age who used acetaminophen at a standard therapeutic dose of 0.5-1g/4-6hrs and were compared against non-users. All 8 studies were assessed for evidence quality using Grading and Recommendations Assessment, Development and Evaluation (GRADE), and all studies had low to very low evidence quality and ultimately had varying definitions of paracetamol dosage. Two of the studies reported increased mortality with those taking the highest levels of acetaminophen compared to non-users. Four studies reported dose-response increases in adverse cardiovascular events, but significantly increased risk of these events were only found at the highest level of acetaminophen usage, which was defined differently for each study. One study reported a dose-response relationship between acetaminophen and adverse gastrointestinal events. Four studies showed an impact of acetaminophen on renal function, with some studies showing a protective event of acetaminophen at low doses and some showing a detrimental effect of acetaminophen at high doses, estimated by measuring glomerular filtration rates.

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: acetaminophen
Previous Post

Novel compound may correct pathological airway mucus in cystic fibrosis [PreClinical]

Next Post

Omeprazole before endoscopy in patients with gastrointestinal bleeding [Classics Series]

RelatedReports

Patients report persistent quality-of-life impairments following ruptured brain aneurysms
Neurology

Triptans may be the most effective treatments available for acute episodic migraine

March 24, 2025
Survival greater in cervical cancer patients undergoing abdominal hysterectomy compared to minimally invasive techniques: the LACC trial
Neurology

Addition of IV acetaminophen with propofol or dexmedetomidine reduces risk of post-operative delirium in older patients undergoing cardiac surgery

February 19, 2019
Computed tomography improves diagnostic certainty in the emergency department
Emergency

Acetaminophen reduces recurrence of febrile seizures in children within same fever episode

October 8, 2018
Long-term Acetaminophen Use in Pregnancy and ADHD
Obstetrics

Long-term Acetaminophen Use in Pregnancy and ADHD

October 30, 2017
Next Post
Classics Series, Landmark Trials in Medicine

Omeprazole before endoscopy in patients with gastrointestinal bleeding [Classics Series]

Hepatitis E vaccine may protect for up to 4.5 years

Hepatitis E vaccine may protect for up to 4.5 years

2 Minute Medicine Rewind November 23 – November 30, 2014

VZVΔG-ZEBOV vaccine may be effective in preventing Ebola virus infection

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Intravenous hydrocortisone may reduce risk of kidney failure in patients with sepsis
  • Sotatercept reduces adverse event risk in high-risk pulmonary arterial hypertension
  • Oral semaglutide reduces cardiovascular event rates in high-risk patients
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.